1. Preparation of curcumin-loaded chitosan/lecithin nanoparticles with increased anti-oxidant activity and in vivo bioavailability.
- Author
-
Yu F, Luo H, Wang Y, Wei Z, Li B, Zhao Y, Wu P, Wang J, Yang H, Gao J, Li Q, Pan J, Chen K, Wang H, Qi Z, and Chen XD
- Subjects
- Animals, Particle Size, Drug Carriers chemistry, Rats, Male, Drug Liberation, Curcumin pharmacokinetics, Curcumin chemistry, Curcumin pharmacology, Curcumin administration & dosage, Chitosan chemistry, Nanoparticles chemistry, Biological Availability, Antioxidants chemistry, Antioxidants pharmacokinetics, Antioxidants pharmacology, Antioxidants administration & dosage
- Abstract
As a natural polyphenol, curcumin (Cur) has exhibited a range of bioactive properties, including anti-inflammatory, anti-oxidant, and anti-infection properties. However, the chemical instability and low water solubility of Cur hinder its wide application. Herein, Cur-loaded chitosan/lecithin nanoparticles (CCL NPs) were prepared by the electrostatic self-assembly method. The prepared CCL NPs showed a small particle size (122.86 ± 1.53 nm) with homogeneous distribution (PDI = 0.17 ± 0.01). The high EE (79.34 ± 2.93 %) and LC (9.33 ± 0.34 %) indicated that most of Cur was encapsulated in CCL NPs. Meanwhile, the Cur was released from CCL NPs in a quick and sustained way after being exposed to simulated gastrointestinal fluids. The CCL NPs displayed superior anti-oxidant activity than that of free Cur. Moreover, the in vivo pharmacokinetic studies showed that the CCL NPs could lead to a ~ 2.64-fold increase in oral bioavailability compared with that of free Cur. All these findings indicated that the formation of CCL NPs would be a promising platform to deliver Cur in the food industry., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF